SPL 2.25% 9.1¢ starpharma holdings limited

Looking Forward, page-2

  1. 1,712 Posts.
    lightbulb Created with Sketch. 113
    thrasher, as you have identified, starpharma seems to have a number of opportunities to develop over the comings 12-24 months.
    These will require funding. Any and all revenue will be banked and earmarked as growth capital. There will be no capital returns (dividends nor buybacks) for the foreseeable future.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.1¢
Change
0.002(2.25%)
Mkt cap ! $37.49M
Open High Low Value Volume
9.0¢ 9.3¢ 9.0¢ $111.8K 1.228M

Buyers (Bids)

No. Vol. Price($)
4 161427 9.0¢
 

Sellers (Offers)

Price($) Vol. No.
9.1¢ 73897 3
View Market Depth
Last trade - 13.49pm 25/06/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.